


Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate

Launch of OncoSTART consortium supporting oncology entrepreneurs

Oncology: Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532

AELIX Therapeutics appoints Dr Melanie Rolli as CEO

MATWIN highlights four innovative projects in the fight against cancer

Clean Biologics SAS acquires Biodextris Inc.

Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target

Tollys appoints Amina Zinaï, MD, as head of clinical development
